机构:[1]The First Affiliated Hospital of Kunming Medical University, Kunming, China昆明医科大学附属第一医院[2]3D Medicines Co. Ltd., Shanghai, China[3]The First Affiliated Hospital of Kunming Medical Unversity, Kunming, China昆明医科大学附属第一医院肿瘤内科内科科室
第一作者机构:[1]The First Affiliated Hospital of Kunming Medical University, Kunming, China[2]3D Medicines Co. Ltd., Shanghai, China[3]The First Affiliated Hospital of Kunming Medical Unversity, Kunming, China
推荐引用方式(GB/T 7714):
Dong Chao,Zhang Hushan,Liu Weiqing,et al.Postoperative prognosis in patients with NSCLC with different EGFR mutation sites[J].JOURNAL OF CLINICAL ONCOLOGY.2023,41(16):
APA:
Dong, Chao,Zhang, Hushan,Liu, Weiqing,Kong, Deyu,Chen, Xiao...&Qian, Ying.(2023).Postoperative prognosis in patients with NSCLC with different EGFR mutation sites.JOURNAL OF CLINICAL ONCOLOGY,41,(16)
MLA:
Dong, Chao,et al."Postoperative prognosis in patients with NSCLC with different EGFR mutation sites".JOURNAL OF CLINICAL ONCOLOGY 41..16(2023)